New Cancer Vaccine Shows Promise in Trial
Pancreatic and colorectal cancers are notoriously difficult to treat and often return after initial therapy. However, a new ready-to-use vaccine, ELI-002 2P, is offering renewed hope after showing encouraging results in a recent clinical trial. Innovative Vaccine Targets KRAS Mutations with Precision Delivery System Created by scientists from various U.S. institutions, the vaccine targets mutations […]
New Cancer Vaccine Shows Promise in Trial Read More »









